These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 35216298

  • 1. The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice.
    Nowicka N, Szymańska K, Juranek J, Zglejc-Waszak K, Korytko A, Załęcki M, Chmielewska-Krzesińska M, Wąsowicz K, Wojtkiewicz J.
    Int J Mol Sci; 2022 Feb 16; 23(4):. PubMed ID: 35216298
    [Abstract] [Full Text] [Related]

  • 2. Novel insights into RAGE signaling pathways during the progression of amyotrophic lateral sclerosis in RAGE-deficient SOD1 G93A mice.
    Nowicka N, Zglejc-Waszak K, Juranek J, Korytko A, Wąsowicz K, Chmielewska-Krzesińska M, Wojtkiewicz J.
    PLoS One; 2024 Feb 16; 19(3):e0299567. PubMed ID: 38457412
    [Abstract] [Full Text] [Related]

  • 3. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner.
    MacLean M, Juranek J, Cuddapah S, López-Díez R, Ruiz HH, Hu J, Frye L, Li H, Gugger PF, Schmidt AM.
    J Neuroinflammation; 2021 Jun 15; 18(1):139. PubMed ID: 34130712
    [Abstract] [Full Text] [Related]

  • 4. Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.
    Lee JD, McDonald TS, Fung JNT, Woodruff TM.
    Mol Neurobiol; 2020 Oct 15; 57(10):4143-4155. PubMed ID: 32676989
    [Abstract] [Full Text] [Related]

  • 5. Effects of RAGE inhibition on the progression of the disease in hSOD1G93A ALS mice.
    Liu L, Killoy KM, Vargas MR, Yamamoto Y, Pehar M.
    Pharmacol Res Perspect; 2020 Aug 15; 8(4):e00636. PubMed ID: 32776498
    [Abstract] [Full Text] [Related]

  • 6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G.
    Neurobiol Dis; 2014 Apr 15; 64():48-59. PubMed ID: 24361555
    [Abstract] [Full Text] [Related]

  • 7. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
    Yoshikawa M, Ishikawa C, Li H, Kudo T, Shiba D, Shirakawa M, Muratani M, Takahashi S, Aizawa S, Shiga T.
    Mol Cell Neurosci; 2022 Jul 15; 121():103745. PubMed ID: 35660087
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Lee JD, Liu N, Levin SC, Ottosson L, Andersson U, Harris HE, Woodruff TM.
    J Neuroinflammation; 2019 Feb 19; 16(1):45. PubMed ID: 30782181
    [Abstract] [Full Text] [Related]

  • 9. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y, Tang C, Zhu L, Li J, Liang H, Zhang J, Xu R.
    Int J Biol Sci; 2016 Feb 19; 12(9):1140-9. PubMed ID: 27570488
    [Abstract] [Full Text] [Related]

  • 10. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Bonifacino T, Cattaneo L, Gallia E, Puliti A, Melone M, Provenzano F, Bossi S, Musante I, Usai C, Conti F, Bonanno G, Milanese M.
    Neuropharmacology; 2017 Sep 01; 123():433-445. PubMed ID: 28645622
    [Abstract] [Full Text] [Related]

  • 11. Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis.
    Brewer MK, Torres P, Ayala V, Portero-Otin M, Pamplona R, Andrés-Benito P, Ferrer I, Gentry MS, Guinovart JJ, Duran J.
    J Neurochem; 2024 May 01; 168(5):744-759. PubMed ID: 37401737
    [Abstract] [Full Text] [Related]

  • 12. Persistent NRG1 Type III Overexpression in Spinal Motor Neurons Has No Therapeutic Effect on ALS-Related Pathology in SOD1G93A Mice.
    Hernández S, Salvany S, Casanovas A, Piedrafita L, Soto-Bernardini MC, Tarabal O, Blasco A, Gras S, Gatius A, Schwab MH, Calderó J, Esquerda JE.
    Neurotherapeutics; 2023 Oct 01; 20(6):1820-1834. PubMed ID: 37733208
    [Abstract] [Full Text] [Related]

  • 13. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1G93A ) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes.
    Kreilaus F, Guerra S, Masanetz R, Menne V, Yerbury J, Karl T.
    Genes Brain Behav; 2020 Feb 01; 19(2):e12604. PubMed ID: 31412164
    [Abstract] [Full Text] [Related]

  • 14. Desloratadine alleviates ALS-like pathology in hSOD1G93A mice via targeting 5HTR2A on activated spinal astrocytes.
    Lu J, He AX, Jin ZY, Zhang M, Li ZX, Zhou F, Ma L, Jin HM, Wang JY, Shen X.
    Acta Pharmacol Sin; 2024 May 01; 45(5):926-944. PubMed ID: 38286832
    [Abstract] [Full Text] [Related]

  • 15. Integrative analysis of metabolomics and proteomics unravels purine metabolism dysregulation in the SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Xu X, Yang Q, Liu Z, Zhang R, Yu H, Wang M, Chen S, Xu G, Shao Y, Le W.
    Neurobiol Dis; 2023 Jun 01; 181():106110. PubMed ID: 37001614
    [Abstract] [Full Text] [Related]

  • 16. CXCR2 Is Deregulated in ALS Spinal Cord and Its Activation Triggers Apoptosis in Motor Neuron-Like Cells Overexpressing hSOD1-G93A.
    La Cognata V, D'Amico AG, Maugeri G, Morello G, Guarnaccia M, Magrì B, Aronica E, D'Agata V, Cavallaro S.
    Cells; 2023 Jul 09; 12(14):. PubMed ID: 37508478
    [Abstract] [Full Text] [Related]

  • 17. IRAK-M Plays A Role in the Pathology of Amyotrophic Lateral Sclerosis Through Suppressing the Activation of Microglia.
    Zhong X, Li C, Li Y, Huang Y, Liu J, Jiang A, Chen J, Peng Y.
    Mol Neurobiol; 2024 Oct 09; 61(10):7603-7610. PubMed ID: 38421467
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation.
    Liu X, Zhang J, Li J, Song C, Shi Y.
    Mol Metab; 2022 Sep 09; 63():101536. PubMed ID: 35772643
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes.
    Bette M, Cors E, Kresse C, Schütz B.
    Int J Mol Sci; 2022 Mar 21; 23(6):. PubMed ID: 35328829
    [Abstract] [Full Text] [Related]

  • 20. The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93A Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes.
    Serrano A, Donno C, Giannetti S, Perić M, Andjus P, D'Ambrosi N, Michetti F.
    Mediators Inflamm; 2017 Mar 21; 2017():1626204. PubMed ID: 28713206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.